You searched for oral corticosteroids

Active Filters

Click on a filter below to refine your search. Remove a filter to broaden your search.

Distributed Content remove

Post remove

Last 2 years remove

Drugs in the Pipeline remove

Relevant Recent

news

Rilzabrutinib is an oral Bruton tyrosine kinase inhibitor currently in development for a number of immune-mediated diseases.

Steve Duffy

September 9, 2021

news

The BLA submission is supported by data from the PATHFINDER clinical program.

Brian Park, PharmD

May 10, 2021